Cargando…

The Alterations and Potential Roles of MCMs in Breast Cancer

The minichromosome maintenance (MCM) protein family plays a key role in eukaryotic DNA replication and has been confirmed to be associated with the occurrence and progression of many tumors. However, the expression levels, functions, and prognostic values of MCMs in breast cancer (BC) have not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xinyu, Liu, Ying, Wang, Qiangshan, Song, Siqi, Feng, Lingjun, Shi, Chunying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407980/ https://www.ncbi.nlm.nih.gov/pubmed/34475953 http://dx.doi.org/10.1155/2021/7928937

Ejemplares similares

MCMs in Cancer: Prognostic Potential and Mechanisms
por: Yu, Si, et al.
Publicado: (2020)

Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients
por: Liu, Xinyu, et al.
Publicado: (2021)

The Expression and Prognostic Roles of MCMs in Pancreatic Cancer
por: Peng, Yun-Peng, et al.
Publicado: (2016)

Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma
por: Lan, Hua, et al.
Publicado: (2021)

MCMs expression in lung cancer: implication of prognostic significance
por: Liu, Yi-Zhen, et al.
Publicado: (2017)

Replication timing is regulated by the number of MCMs loaded at origins
por: Das, Shankar P., et al.
Publicado: (2015)

Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer
por: Guo, Fan, et al.
Publicado: (2020)

Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer
por: Cheng, Lin, et al.
Publicado: (2020)

Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
por: Sun, Lin, et al.
Publicado: (2021)

Routing in the third dimension: from VLSI chips to MCMs
por: Sherwani, N A, et al.
Publicado: (1995)

The Changing Landscape for New Drug Development: Medical Countermeasures (MCMs) as a Case Study
por: Milne, Christopher-Paul
Publicado: (2019)

Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic
por: Eren Vural, Ipek, et al.
Publicado: (2023)

Prognostic importance of expression of mini-chromosome maintenance proteins (MCMs) in patients with nasopharyngeal cancer treated with curative radiotherapy
por: Kanyilmaz, Gul, et al.
Publicado: (2021)

Identification of ZG16B as a prognostic biomarker in breast cancer
por: Lu, Haotian, et al.
Publicado: (2020)

Specific bFGF targeting of KIM-1 in ischemic kidneys protects against renal ischemia-reperfusion injury in rats
por: Song, Siqi, et al.
Publicado: (2022)

TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk
por: Chen, Ying, et al.
Publicado: (2016)

Evaluation of a population-based breast cancer screening in North China
por: Wu, Siqi, et al.
Publicado: (2023)

Supramolecular Precursor Strategy to Construct g-C(3)N(4)/Silica Hybrid Nanosheets for Photocatalytic Degradation of Dye and Antibiotic Pollutants
por: Yu, Yongsheng, et al.
Publicado: (2022)

Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis
por: Li, Jin‐Yue, et al.
Publicado: (2022)

Profiles of social constraints and associated factors among breast cancer patients: a latent profile analysis
por: Cui, ChunYing, et al.
Publicado: (2022)

Locoregional Therapy in De novo Metastatic Breast Cancer: A Retrospective Cohort Study
por: Jianna, Sun, et al.
Publicado: (2022)

TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
por: Wu, Kunlin, et al.
Publicado: (2018)

VWCE as a potential biomarker associated with immune infiltrates in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer
por: Ma, Ji, et al.
Publicado: (2020)

Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer
por: Liu, Zihao, et al.
Publicado: (2022)

Synthesis and Characterization of Single-Phase α-Cordierite Glass-Ceramics for LTCC Substrates from Tuff
por: Yu, Yongsheng, et al.
Publicado: (2022)

Identification of the potential roles of ring finger protein 8 in TP53-mutant breast cancer
por: Zhao, Feng, et al.
Publicado: (2021)

Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis
por: Liu, Yingyu, et al.
Publicado: (2018)

Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations
por: Bertucci, François, et al.
Publicado: (2020)

The role of developing breast cancer in alteration of serum lipid profile
por: Abdelsalam, Kamal Eldin A., et al.
Publicado: (2012)

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin
por: He, Ye, et al.
Publicado: (2015)

Health-related quality of life and social constraints among Chinese breast cancer patients: a cross-sectional study
por: Cui, Chunying, et al.
Publicado: (2021)

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
por: Wu, Hao-Xiang, et al.
Publicado: (2019)

Genetic alterations of histone lysine methyltransferases and their significance in breast cancer
por: Liu, Lanxin, et al.
Publicado: (2014)

Genetic modulation of RAP alters fruit coloration in both wild and cultivated strawberry
por: Gao, Qi, et al.
Publicado: (2020)

Right or Left: The Role of Nanoparticles in Pulmonary Diseases
por: Lu, Xuefei, et al.
Publicado: (2014)

Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

The potential role of somatostatin analogues in breast cancer treatment.
por: Pollak, M.
Publicado: (1997)

IL-22 promotes tumor growth of breast cancer cells in mice
por: Zhang, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lbj1ok8ee01d5d4adn35a8d0b6